Phase II study of gemcitabine, trastuzumab, and pertuzumab in the treatment of metastatic HER2-positive breast cancer after prior trastuzumab/pertuzumab- or pertuzumab-based therapy Meeting Abstract

  

Authors:	Iyengar, N. M.; Argolo, D.; Smyth, L.; Chen, M. F.; Hudis, C. A.; Dang, C. T.
Abstract Title:	Phase II study of gemcitabine, trastuzumab, and pertuzumab in the treatment of metastatic HER2-positive breast cancer after prior trastuzumab/pertuzumab- or pertuzumab-based therapy
Meeting Title:	38th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS)
Journal Title:	Cancer Research
Volume:	76
Issue:	4 Suppl.
Meeting Dates:	2015 Dec 8-12
Meeting Location:	San Antonio, TX
ISSN:	0008-5472
Publisher:	American Association for Cancer Research
Date Published:	2016-02-15
Language:	English
ACCESSION:	WOS:000375622401257
DOI:	10.1158/1538-7445.sabcs15-ot3-01-09
PROVIDER:	wos
Notes:	Meeting Abstract: OT3-01-09 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/95162